Sponsorships

Reach clinicians who actually read.

The Med 5 delivers a 70%+ open rate to a verified audience. Every reader is a practicing clinician or trainee in your target specialty who is the decision maker when it comes to prescribing.

0+

Verified Clinicians

0%+

Average open rate

0

Active specialties

0+

Daily Views

0+

Daily Views

Who you're reaching

The audience

~65%

Attending physicians

Board-certified specialists in active practice — the prescribers and procedure decision-makers you're trying to reach.

~15%

APPs & allied health

Physician assistants, NPs, and other advanced practice providers in specialty settings.

~15%

APPs & allied health

Physician assistants, NPs, and other advanced practice providers in specialty settings.

~20%

Residents & fellows

Trainees building clinical habits and brand familiarity early in their careers.

~20%

Residents & fellows

Trainees building clinical habits and brand familiarity early in their careers.

Derm-focused

Currently dermatology-led

The Derm 5 drives the majority of current subscribers. Ortho and Plastics audiences growing with 2026 launches.

Sponsorship formats

Options

FORMAT

Starting at

Includes

Presenting sponsor

Contact us / Per week

Logo placement · Brand mention in opener · 1 sponsored content slot · Metrics report

Sponsored content

Contact us / Per placement

One issue placement · Editor-reviewed copy · Click tracking · Open/CTR report

Multi-publication package

Contact us / Custom pricing

Cross-specialty placement · Dedicated account contact · Bundled metrics · Custom scheduling

All sponsorships are subject to editorial review. The Med 5 does not publish content that conflicts with its editorial standards. Pharma sponsors must comply with applicable FDA promotional guidelines.

CURRENT PARTNERS

Media kit

Request the media kit

YOUR NAME

COMPANY / BRAND

WORK EMAIL

WHICH SPECIALTIES ARE YOU TARGETING?

© 2026 The Med 5. All rights reserved.

© 2026 The Med 5. All rights reserved.

© 2026 The Med 5. All rights reserved.